This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biotechrss

Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst

Fate Therapeutics (FATE) is developing several small molecules which modulate umbilical cord stem cells.

07/30/15 - 12:37 PM EDT

MannKind Afrezza Sales Underwhelming Again, Sanofi Reports

  • Tickers in this article:
  • MNKD
  • SNY

The only saving grace is that no one, not even the most Kool-Aid-drinking MannKind supporter, is surprised by Afrezza's poor sales.

07/30/15 - 11:03 AM EDT

IBM, CVS Will Use Watson Health Technology to Improve Patient Care

IBM, CVS Will Use Watson Health Technology to Improve Patient Care

IBM and CVS announced a joint venture Thursday that will use Watson technology to help those with chronic conditions track and maintain health goals.

07/30/15 - 12:01 AM EDT

MannKind Afrezza Sales Underwhelming Again, Sanofi Reports

MannKind Afrezza Sales Underwhelming Again, Sanofi Reports

  • Tickers in this article:
  • MNKD
  • SNY

The only saving grace is that no one, not even the most Kool-Aid-drinking MannKind supporter, is surprised by Afrezza's poor sales.

07/30/15 - 11:03 AM EDT

Cytec Industries Rockets Higher on Deal; Stocks Gain Ahead of Fed

Cytec Industries Rockets Higher on Deal; Stocks Gain Ahead of Fed

Cytec Industries (CYT) surged Wednesday after Belgian company Solvay agreed to buy the chemicals specialist for $6.4 billion, including debt.

07/29/15 - 11:55 AM EDT

Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good)

Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good)

Gilead Sciences will not be blamed for a cooling of the biotech bull market, if any such thing exists.

07/28/15 - 04:15 PM EDT

Nymox Pharmaceutical (NYMX) Stock Higher on Positive Test Results

Nymox Pharmaceutical (NYMX) Stock Higher on Positive Test Results

  • Tickers in this article:
  • NYMX

Nymox Pharmaceutical (NYMX) shares continue to climb on promising BPH treatment candidate results.

07/28/15 - 12:44 PM EDT

Pfizer Beats Estimates Following Strong Sales of Cancer Drugs

Pfizer Beats Estimates Following Strong Sales of Cancer Drugs

  • Tickers in this article:
  • PFE

Pfizer (PFE) reported earnings on Tuesday that beat estimates and raised its outlook for the year as newly launched drug treatments continued to perform well in the the second quarter.

07/28/15 - 12:05 PM EDT

Struggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO Launches

Struggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO Launches

It's a day that ends in "day," which means cancer immunotherapy is dominating the biotech news.

07/28/15 - 10:23 AM EDT

Teva Makes Right Choice, Baidu Looks Weak, Yelp Gets Own Review

Teva Makes Right Choice, Baidu Looks Weak, Yelp Gets Own Review

In Tuesday’s Analysts' Actions, Wall Street firms review Teva Pharmaceutical Industries (TEVA), Baidu (BIDU), and Yelp (YELP).

07/28/15 - 10:09 AM EDT

U.S. Stocks Open Higher; Federal Reserve Begins 2-Day Meeting

U.S. Stocks Open Higher; Federal Reserve Begins 2-Day Meeting

U.S. stocks opened higher Tuesday as the Federal Reserve begins its 2-day meeting today on the economy and interest rates.

07/28/15 - 09:49 AM EDT

Watching Twitter for Moves at Teva and Biogen

Watching Twitter for Moves at Teva and Biogen

Twitter sentiment predicts the big moves in two healthcare stocks-NYMX and BIIB.

07/28/15 - 08:28 AM EDT

What to Watch Tuesday: FOMC Meeting, Twitter Earnings, Consumer Data

What to Watch Tuesday: FOMC Meeting, Twitter Earnings, Consumer Data

For Tuesday July 28, TheStreet highlights the Federal Open Market Committee meeting, the key earnings reports and economic data to watch on Wall Street.

07/27/15 - 08:00 PM EDT

Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid

Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid

Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.

07/27/15 - 05:47 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

Chart of I:DJI
DOW 17,753.10 +1.71 0.01%
S&P 500 2,108.23 -0.34 -0.02%
NASDAQ 5,129.9750 +18.2420 0.36%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs